Intravenous injection of bone marrow-derived stem cells
(MSCs) in patients with spinal cord injuries led to significant improvement in
motor functions, researchers from Yale University and Japan report Feb. 18 in
the Journal of Clinical Neurology and Neurosurgery.
For more than half of the patients, substantial improvements
in key functions — such as ability to walk, or to use their hands — were
observed within weeks of stem cell injection, the researchers report. No
substantial side effects were reported.
The patients had sustained non-penetrating spinal cord
injuries, in many cases from falls or minor trauma, several weeks prior to
implantation of the stem cells. Their symptoms involved loss of motor function
and coordination, sensory loss, as well as bowel and bladder dysfunction. The
stem cells were prepared from the patients’ own bone marrow, via a culture
protocol that took a few weeks in a specialized cell processing centre. The
cells were injected intravenously in this series, with each patient serving as
their own control. Results were not blinded and there were no placebo controls.
Yale scientists Jeffery D. Kocsis, professor of neurology
and neuroscience, and Stephen G. Waxman, professor of neurology, neuroscience
and pharmacology were senior authors of the study, which was carried out with
investigators at Sapporo Medical University in Japan. Key investigators of the
Sapporo team, Osamu Honmou and Masanori Sasaki, both hold adjunct professor
positions in neurology at Yale.
Kocsis and Waxman stress that additional studies will be
needed to confirm the results of this preliminary, unblinded trial. They also
stress that this could take years. Despite the challenges, they remain
optimistic.
“Similar results with stem cells in patients with stroke
increases our confidence that this approach may be clinically useful,” noted
Kocsis. “This clinical study is the culmination of extensive preclinical
laboratory work using MSCs between Yale and Sapporo colleagues over many
years.”
“The idea that we may be able to restore function after
injury to the brain and spinal cord using the patient’s own stem cells has
intrigued us for years,” Waxman said. “Now we have a hint, in humans, that it
may be possible.”
References:

Comments
Post a Comment